Serum levels of soluble Fas and disease activity in patients with IgA nephropathy

Nephron

Volumn 81, Issue 4, 1999, Pages 387-392

  Shou, Ichiyu ^a   Tashiro, Kyouichi ^a   Kurusu, Atushi ^a   Kaneko, Shougo ^a   Hayashi, Takeshi ^a   Fukui, Mitumine ^a   Shirato, Isao ^a   Kubota, Kiichi ^b   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shiga University of Medical Science   (Japan)

Author keywords

ELISA; IgA nephropathy; Proteinuria; Renal injury; s Fas

Indexed keywords

FAS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN BLOOD LEVEL; PROTEINURIA;

EID: 0032986029     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045321     Document Type: Article

References (34)

1. Berger J, Hinglasis N: Les dépôts intercapillaires d'IgA-IgG. J Urol Nephrol 1968;74:694-695.
2. Tomino Y: The future: A Japanese perspective; in Clarkson AR (ed): IgA Nephropathy. Boston, Nijhoff, 1987, pp 225-233.
3. Brentjens JR, Sepulveda M, Baliah T, Bentzel C, Erlanger BF, Elwood C, Montes M, Hsu KC, Andres GA: Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 1975;7:342-350.
4. Tomino Y, Ohmuro H, Kuramoto T, Shirato I, Eguchi K, Sakai H, Okumura K, Koide H: Expression of intercellular adhesion molecule-1 and infiltration of lymphocytes in glomeruli of patients with IgA nephropathy. Nephron 1994;67:302-307.
5. Tomino Y, Ozaki T, Koide H, Takahashi M, Ito K: Serum levels of interleukin-2 receptor and disease activity in patients with IgA nephropathy. J Clin Lab Anal 1989;3:355-359.
6. Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Shirato I, Shirai T, Takahashi M, Koide H: Urinary interleukin-6 and disease activity in patients with IgA nephropathy. Am J Nephrol 1991;11:459-464.
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243.
8. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagat S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
9. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richard S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 1992;267: 10709-10715.
10. Watanabe-Fukunaga R, Brannan Cl, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
11. Watson ML, Rao JK, Gilkeson GS, Ruizu P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF: Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestation and renal disease-modifying loci. J Exp Med 1992;176: 1645-1656.
12. Adachi M, Watanabe-Fukuda R, Nagata S: Aberrant transcription caused by the insertion of an early transposable element in intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993;90:1756-1760.
13. Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW: Expression of CD69 after in vitro stimulation: A rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11: 95-104.
14. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263: 1759-1762.
15. Jodo S, Kobayashi S, Kayagaki N, Ogura N, Feng Y, Amasaki Y, Fujisaka A, Azuma M, Yagita H, Okumura K, Koike T: Serum levels of soluble Fas/APO-1 (CD95) and its molecule structure in patients with systemic lupus erythematosus (SLE) and other autoimmune disease. Clin Exp Immunol 1997;107:89-95.
16. Tashiro K, Kodera S, Takahashi Y, Horikoshi S, Shirato I, Tomino Y: Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron 1998;79:21-27.
17. Tomino Y, Sakai H, Endoh M, Kaneshige H, Nomoto Y: Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Clin Immunol Immunopathol 1982;24:63-71.
18. Sakai H, Abe K, Kobayashi Y, Koyama A, Shigematsu H, Harada T, Yoshikawa N, Arakawa M, Itoh H, Osawa G, Sakai O, Dohi K, Yamanaka N, Nagasawa T, Kurokawa K: Clinical guidelines of IgA nephropathy. Jpn J Nephrol 1995;37:417-421.
19. Saitoh A, Suzuki Y, Takeda M, Kubota K, Tomino Y: Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy. J Clin Lab Anal 1998;12:1-5.
20. Rosner B: Fundamentals of Biostatistics, ed 3. PWS-KENT Publishing Company, 1990.
21. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer 1972;26:239-257.
22. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996;49:103-111.
23. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 1996;74:941-951.
24. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994;94: 2105-2116.
25. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995;47:114-121.
26. Yasumoto K, Nagasawa H, Uehara H, Hisaeda H, Kagami S, Okada Y, Himeno K: The novel regulatory mechanism of Fas system-mediated apoptosis in mesangial cells: Implication to mesangial proliferative glomerulonephritis. Biochem Biophys Res Commun 1996;219:89-95.
27. Yoshimura A, Sugenoya Y, Uda S, Inui K, Iwasaki S, Taira T, Ideura T: Expression of apoptosis-preventing Bcl-2 protein and inducing Fas antigen in glomeruli of IgA nephropathy. Contrib Nephrol 1996;118:48-53.
28. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 1996;7:2357-2363.
29. Kitamura M, Fine LG: Evidence for TGF-beta-mediated 'defense' of the glomerulus: A black-guard molecule rehabilitated? Exp Nephrol 1998;6:1-6.
30. Diamond JR, Bonventre JV, Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 1986;29:478-483.
31. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
32. Itoh N, Tsujimoto Y, Nagata S: Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627.
33. Nagata M, Nakauchi H, Nakayama K, Loh D, Watane T: Apoptosis during an early stage of nephrogenesis induces renal hypoplasia in bcl-2 deficient mice. Am J Pathol 1996;148:1601-1611.
34. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and bcl-2 in human glomerulonephritis. Kidney Int 1995;48:1886-1892.